Involvement of quinolinic acid in AIDS dementia complex - PubMed (original) (raw)

Review

Involvement of quinolinic acid in AIDS dementia complex

Gilles J Guillemin et al. Neurotox Res. 2005.

Abstract

Human immunodeficiency virus (HIV) infection is often complicated by the development of acquired immunodeficiency syndrome (AIDS) dementia complex (ADC). Quinolinic acid (QUIN) is an end product of tryptophan, metabolized through the kynurenine pathway (KP) that can act as an endogenous brain excitotoxin when produced and released by activated macrophages/microglia, the very cells that are prominent in the pathogenesis of ADC. This review examines QUIN's involvement in the features of ADC and its role in pathogenesis. We then synthesize these findings into a hypothetical model for the role played by QUIN in ADC, and discuss the implications of this model for ADC and other inflammatory brain diseases.

PubMed Disclaimer

Similar articles

• CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
  Valle M, Price RW, Nilsson A, Heyes M, Verotta D. Valle M, et al. Brain. 2004 May;127(Pt 5):1047-60. doi: 10.1093/brain/awh130. Epub 2004 Mar 10. Brain. 2004. PMID: 15013955
• Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
  Yan EB, Frugier T, Lim CK, Heng B, Sundaram G, Tan M, Rosenfeld JV, Walker DW, Guillemin GJ, Morganti-Kossmann MC. Yan EB, et al. J Neuroinflammation. 2015 May 30;12:110. doi: 10.1186/s12974-015-0328-2. J Neuroinflammation. 2015. PMID: 26025142 Free PMC article.
• Neurocytotoxity of quinolinic acid in human brain cultures.
  Kerr SJ, Armati PJ, Brew BJ. Kerr SJ, et al. J Neurovirol. 1995 Dec;1(5-6):375-80. doi: 10.3109/13550289509111027. J Neurovirol. 1995. PMID: 9222380
• Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis.
  Guillemin GJ, Meininger V, Brew BJ. Guillemin GJ, et al. Neurodegener Dis. 2005;2(3-4):166-76. doi: 10.1159/000089622. Neurodegener Dis. 2005. PMID: 16909022 Review.

Cited by

• CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.
  Yadav A, Collman RG. Yadav A, et al. J Neuroimmune Pharmacol. 2009 Dec;4(4):430-47. doi: 10.1007/s11481-009-9174-2. Epub 2009 Sep 19. J Neuroimmune Pharmacol. 2009. PMID: 19768553 Free PMC article. Review.
• Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons.
  Braidy N, Grant R, Adams S, Brew BJ, Guillemin GJ. Braidy N, et al. Neurotox Res. 2009 Jul;16(1):77-86. doi: 10.1007/s12640-009-9051-z. Epub 2009 Apr 18. Neurotox Res. 2009. PMID: 19526301
• Quinolinic acid: an endogenous neurotoxin with multiple targets.
  Lugo-Huitrón R, Ugalde Muñiz P, Pineda B, Pedraza-Chaverrí J, Ríos C, Pérez-de la Cruz V. Lugo-Huitrón R, et al. Oxid Med Cell Longev. 2013;2013:104024. doi: 10.1155/2013/104024. Epub 2013 Sep 5. Oxid Med Cell Longev. 2013. PMID: 24089628 Free PMC article. Review.
• Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression.
  Sundaram G, Lim CK, Brew BJ, Guillemin GJ. Sundaram G, et al. J Neuroinflammation. 2020 Jun 6;17(1):176. doi: 10.1186/s12974-020-01844-y. J Neuroinflammation. 2020. PMID: 32505212 Free PMC article.
• Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease.
  Ting KK, Brew BJ, Guillemin GJ. Ting KK, et al. J Neuroinflammation. 2009 Dec 10;6:36. doi: 10.1186/1742-2094-6-36. J Neuroinflammation. 2009. PMID: 20003262 Free PMC article.

References

1. 1. AIDS. 1998 Mar 5;12(4):355-63 - PubMed
2. 1. Neurosci Lett. 1992 Oct 12;145(2):234-5 - PubMed
3. 1. Exp Neurol. 2001 Jan;167(1):196-204 - PubMed
4. 1. Br J Pharmacol. 2002 Mar;135(6):1435-42 - PubMed
5. 1. Neurology. 1991 Jan;41(1):69-74 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer